The Autoinjectors Global Market Report 2023 by The Business Research Company, provides autoinjectors market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten-year historic period – 2010-2021, and a ten-year forecast period – 2023-2032.

Learn More On The Autoinjectors Market:
https://www.thebusinessresearchcompany.com/report/autoinjectors-global-market-report

According to The Business Research Company’s Autoinjectors Global Market Report 2023, the global autoinjectors market size grew from $2.47 billion in 2022 to $3.01 billion in 2023 at a compound annual growth rate (CAGR) of 21.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The autoinjectors market size is expected to grow to $6.51 billion in 2027 at a CAGR of 21.3%.

The increasing prevalence of chronic diseases is expected to fuel the growth of the autoinjectors market in the coming years. Chronic diseases are described as illnesses that last a year or longer and necessitate continuing medical attention. Chronic diseases such as heart disease, cancer, rheumatoid arthritis, and diabetes are the world's top causes of mortality and disability. Auto injection devices are intended for multiple injections of biologics and hormones in patients who require regular dosage for long-term management of medical circumstances such as diabetes and rheumatoid arthritis.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=5249&type=smp

The autoinjectors market is segmented:
1) By Type: Disposable Autoinjectors, Reusable Autoinjectors
2) By Therapy: Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Other Therapies
3) By Route Of Administration: Subcutaneous, Intramuscular
4) By Distribution Channel: Online Retailer, Pharmacy
5) By End User: Home Care Settings, Hospitals And Clinics, Other End-Users

The growing technological advancements are shaping the autoinjectors market. Major players operating in the autoinjectors sector are focused on developing technological solutions for autoinjectors to meet the demand for a viscous biologics delivery mechanism. For instance, in February 2021, Becton Dickinson (BD), a US-based medical device company is developing Intevia 2.25 mL based on thinner wall cannula technology. The Intevia 2.25 mL is a patient-centric device that works seamlessly with BD NeopakXtraFlowprefillable syringes and has an 8-millimeter needle with a thinner wall.

Top Major Players
AbbVie,
Mylan,
Eli Lilly and Company,
Amgen,
Becton Dickinson and Company

The autoinjectors market report table of contents includes:
1. Executive Summary
2. Autoinjectors Market Characteristics
3. Autoinjectors Market Trends And Strategies
4. Autoinjectors Market – Macro Economic Scenario
5. Autoinjectors Market Size And Growth
6. Autoinjectors Market Segmentation
7. Autoinjectors Market Regional And Country Analysis
...................
28. Key Mergers And Acquisitions In The Autoinjectors Market
29. Autoinjectors Market Future Outlook and Potential Analysis
30. Appendix

List Of Tables:
Table 1: Global Historic Market Growth, 2017-2022, $ Billion
Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Table 3: Global Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 4: Global Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 5: Global Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
...........
Table 48: AbbVie Financial Performance
Table 49: Mylan Financial Performance
Table 50: Eli Lilly and Company Financial Performance
Table 51: Amgen Financial Performance
Table 52: Becton Dickinson and Company Financial Performance

Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn:https://in.linkedin.com/company/the-business-research-company
Twitter:https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog:https://blog.tbrc.info/
Healthcare Blog:https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model